Catalent today announced the appointment of Ricci Whitlow as President, Clinical Supply Services. Ms. Whitlow succeeds Paul Hegwood, who plans to retire in March 2020.

Catalent, a global leader in clinical supply services, today announced the launch of FlexDirect™, a new direct-to-patient service for clinical trials.

Catalent was recently awarded a certificate of recognition from the Tangzhen, China government to acknowledge the company’s successful investment and operations in the region.

Catalent today announced the launch of its new CTSuccess™ clinical trial planning service, designed to support trial sponsors with earlier, more proactive and robust clinical supply chain planning, and reduce the risk of delays and budget overspend common to clinical trials as they progress.

Catalent today announced that Ann McMahon, Program Director, Clinical Supply Services and Drug Product Technologies Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health and Personal Care Logistics Conference (HPCLC) on Oct. 28 – 30, 2019.

Catalent today announced that Mark Woolf, its Director of Depot Networks, will present at the upcoming 6th Annual Global Clinical Supplies Group European Knowledge Forum, to be held in Cascais, Portugal, on Oct. 22 – 24, 2019.

Catalent today announced that Guy J. Dewil, M.D. has been appointed General Manager of its clinical supply facility in Schorndorf, Germany.

Catalent today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in Asia on Sept. 25 – 26, 2019.

Catalent today announced it is to invest $9 million in a new clinical supply facility in San Diego, due to open in the summer of 2020.